DIASOME PHARMACEUTICALS
Diasome Pharmaceuticals is a clinical stage diabetes therapeutics company that designs and develops insulin-based therapies. The company’s products include Oral HVD-I, a targeted oral insulin in a pill or gel cap dose form; HDV-I, an injectable short acting insulin; and HDV-B, an injectable basal long acting insulin. It develops products for patients suffering from Type 1 and Type 2 diabetes. Diasome Pharmaceuticals was founded in 2004 and is based in Conshohocken, Pennsylvania.
DIASOME PHARMACEUTICALS
Industry:
Biotechnology Health Care Life Science Medical Therapeutics
Founded:
2004-01-01
Address:
Cleveland, Ohio, United States
Country:
United States
Website Url:
http://www.diasome.com
Total Employee:
1+
Status:
Active
Contact:
216-444-7110
Email Addresses:
[email protected]
Total Funding:
66.27 M USD
Technology used in webpage:
Amazon GoDaddy DNS AWS Global Accelerator GoDaddy Email
Similar Organizations
Aditum Bio
Aditum Bio is an investment fund that specializes in acquiring and developing pharmaceutical assets.
Akili Interactive Labs
Akili is a digital therapeutics company that offers Innovative video game-based therapies for neurological and psychiatric conditions.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Apollo Intelligence
Apollo Intelligence provides healthcare organizations with data-driven decision-making solutions.
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
BioMotiv
BioMotiv is a therapeutic accelerator developing a portfolio of novel medicines.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Cytrellis Biosystems
Cytrellis is a medical technology company that develops aesthetic devices.
Juniper Publishers
Juniper Publishers Inc. is an excellent platform for all the researchers and professors to publish their valued articles.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
Ontera
Ontera develops a hand-held point of use diagnostic platform that examines DNA and RNA, and analytes from any life form.
Principia Pharmaceutical Corporation
Principia Pharmaceutical Corporation has created a revolutionary new way to design and develop oral small molecule therapies.
Remedy Plan Therapeutics
Remedy Plan is a pre-clinical cancer therapeutics company developing first-in-class small molecule drugs that differentiate cancer cells.
Rho Pharmaceuticals
Rho Pharmaceuticals is an early stage life sciences company with one program in clinical development.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Sensei Biotherapeutics
Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies.
Vial
Scalable biotech advancing clinical programs with cost-effective trials and computationally designed therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
Medicxi
Medicxi investment in Venture Round - Diasome Pharmaceuticals
McDonald Partners
McDonald Partners investment in Venture Round - Diasome Pharmaceuticals
JDRF T1D Fund
JDRF T1D Fund investment in Venture Round - Diasome Pharmaceuticals
Black Beret Life Sciences
Black Beret Life Sciences investment in Venture Round - Diasome Pharmaceuticals
Devon Park BioVentures
Devon Park BioVentures investment in Series B - Diasome Pharmaceuticals
Quaker BioVentures
Quaker BioVentures investment in Series B - Diasome Pharmaceuticals
Official Site Inspections
http://www.diasome.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Diasome Pharmaceuticals"
Who We Are - Diasome
Dr. Muchmore joined Diasome in 2016 and has led the execution of multiple HDV Insulin human clinical trials, including the Company’s ISLE-1 Phase 2b study of HDV Insulin in patients with …See details»
Diasome Pharmaceuticals - Crunchbase Company …
Diasome Pharmaceuticals is a clinical stage diabetes therapeutics company that designs and develops insulin-based therapies. The company’s products …See details»
Diasome
At Diasome we are pioneering the science and understanding of hepatocyte cells impact on whole body metabolism to create medicines that transform human health. These cells …See details»
Press Release - diasome.com
Jan 13, 2022 In light of the ongoing challenges that people with type 1 and type 2 diabetes face globally, Diasome’s work has significant potential to solve long-standing problems in diabetes …See details»
Diasome Pharmaceuticals - Funding, Financials, Valuation
Diasome Pharmaceuticals is funded by 6 investors. Medicxi and McDonald Partners are the most recent investors. Diasome Pharmaceuticals has a post-money valuation in the range of $100M …See details»
Diasome Pharmaceuticals, Inc., a clinical stage biopharmaceutical ...
Diasome Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on developing novel, cell targeted therapies for treating diabetes and obesity, and Lyfebulb, LLC, …See details»
Diasome Pharmaceuticals Appoints Peter Tollman, Ph.D., as …
Diasome aims to deliver superior patient outcomes and enhanced disease management by leveraging the hepatocyte's natural regulatory functions. Kent Manson Diasome …See details»
Diasome 2025 Company Profile: Valuation, Funding & Investors
Diasome General Information Description. Developer of novel and cell-targeted therapies designed to treat diabetes, obesity, and other metabolic conditions. The company's therapies leverage technology, an insulin additive, to lessen the instances of high and low blood sugar levels in people with diabetes, enabling patients to get novel proprietary liver-targeted insulins …See details»
Diasome Pharmaceuticals - Crunchbase
Diasome Pharmaceuticals is a clinical-stage diabetes therapeutics company that designs and develops insulin-based therapies. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Diasome - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 8, 2025 Diasome Pharmaceuticals has filed a notice of an exempt offering of securities to raise $15,555,620.00 in New Equity Investment.intelligence360 • Sep 20, 2024 • Diasome Diasome Announces Substantial Reductions in Level 2 Hypoglycemia Events in its Phase 2b OPTI-1 Study of Hepatocyte Directed Vesicle Technology in Type 1 Diabetes GlobeNewswire …See details»
Diasome announces appointment of biopharma thought leader …
Jan 13, 2022 Diasome Pharmaceuticals, Inc., a life sciences company focused on the development of novel therapies for the treatment of diabetes and other metabolicSee details»
Diasome Pharmaceuticals - Org Chart, Teams, Culture & Jobs
View Diasome Pharmaceuticals' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. Sign up. Log in. Diasome Pharmaceuticals. Follow. Join to edit. Diasome Pharmaceuticals is a clinical stage diabetes therapeutics company that designs and develops insulin-based therapies.See details»
Kent Manson - Commercial D.. - Diasome Pharmaceuticals
Commercial Development Vice President, Strategy at Diasome Pharmaceuticals. Kent Manson is a Commercial Development Vice President, Strategy at Diasome Pharmaceuticals based in …See details»
Diasome Pharmaceuticals - VentureRadar
Diasome Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity. Based on more than thirty years of research and development in the fields of cell receptor targeting, insulin formulation, and hepatic (liver) glucose metabolism, the ...See details»
Diasome Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Mar 8, 2025 Explore Diasome Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 7 clinical trials, 1 news, and 3 literature, Disease Domain:Immune System Diseases, Endocrinology and Metabolic Disease, Technology Platform:Unknown, Biosimilar, Hormone, Drug:Insulin lispro biosimilar (Diasome Pharmaceuticals, Inc.), HDV ...See details»
Diasome’s Liver Targeted Insulin | LifeSci Public Relations
We spoke with Robert Geho, CEO of Diasome Pharmaceuticals, Inc. — www.diasome.com — about its nanotechnology additive that delivers insulin to the liver where it can substantially …See details»
Six Organizational Models for Data Science
Introduction. Data science teams can operate in myriad ways within a company. These organizational models influence the type of work that the team does, but also the team’s …See details»
Diasome
Our Purpose with Diasome’s CEO, Robert Geho. 02 The Diabetes Challenge. Outcomes in diabetes are not improving. With over 10 classes of drugs and 10 different insulins, anti-diabetic medications make up the largest annual revenue generating drug category in the U.S. More Americans die from diabetes every year than from AIDS and breast cancer ...See details»
Diasome Pharmaceuticals - Contacts, Employees, Board Members, …
Diasome Pharmaceuticals is a clinical-stage diabetes therapeutics company that designs and develops insulin-based therapies. ... Solutions. Products. Resources. Pricing. Resources. Log In. Organization. Diasome Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights ...See details»
Diasome Pharmaceuticals Appoints Peter Tollman, Ph.D., as …
Diasome's Hepatocyte Targeting Platform reestablishes hepatocyte function, addressing the root cause of dysregulations central to major metabolic diseases such as diabetes, obesity, and …See details»